Trial reportJournal of orthopaedic surgery and research2026
Delta large-channel endoscopy versus unilateral biportal endoscopy for cervicothoracic junction disc herniation: a prospective randomized controlled trial.
Trial report in Journal of orthopaedic surgery and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDue to the obscuration by the sternum, trachea, and major blood vessels, the anterior surgical approach for cervicothoracic junction disc herniation (CTJDH) is extremely challenging. Delta large-channel endoscopy and unilateral biportal endoscopy (UBE) provide posterior decompression and have demonstrated promising clinical potential. This prospective randomized controlled study aims to compare the clinical outcomes of Delta and UBE endoscopic surgeries.
methodsA total of 63 patients were randomly assigned to either the Delta group (n = 32) or the UBE group (n = 31). The primary outcomes were the Neck Disability Index (NDI) and intraoperative blood loss (IBL). Secondary outcomes included VAS, JOA scores, modified MacNab criteria, operative time, hospital stay duration, perioperative complications, and radiographic parameters.
resultsDuring the follow-up period, 62 patients (98.4%) completed the 6-month assessment. The Delta group consistently demonstrated lower NDI scores than the UBE group. Significant differences were observed at postoperative day 14 (p = 0.040) and one month (p = 0.035), favoring the Delta technique. Intraoperative blood loss was significantly lower in the Delta group than in the UBE group (p < 0.001). At postoperative day 3 (p = 0.037), day 7 (p = 0.034), day 14 (p = 0.041), and 1 month (p = 0.027), neck VAS scores were lower in the Delta group. Operative time was shorter in the UBE group (p < 0.001). Both groups showed significant postoperative increases in the C2-C7 Cobb angle (p < 0.001) and reductions in cervical sagittal vertical axis (cSVA) (p < 0.05). Delta group patients with osteophytes had consistently higher NDI scores than those without osteophytes.
conclusionBoth surgical techniques demonstrated favorable safety profiles and clinical efficacy in the treatment of CTJDH. Compared with UBE, the Delta large-channel endoscopic approach resulted in less intraoperative blood loss and faster postoperative recovery, although it required a longer operative time. For patients with CTJDH accompanied by osteophytes or bony overgrowth, UBE provided equally satisfactory outcomes, whereas the Delta technique showed relatively poorer results in such cases. Therefore, the choice of surgical approach should be individualized based on each patient's anatomical characteristics and clinical presentation. Trial registration Name of the registry: Chinese Clinical Trial Registry chictr.org.cn. Unique Identifying number or registration ID: ChiCTR2500097522.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.